Table 5.
Marker | Positive (Number/Ratio) | Negative (Number/Ratio) | ||
---|---|---|---|---|
P63 | 0 | 20 (100%) | ||
Calcitonin | 0 | 20 (100%) | ||
TTF1 | 20 (100%) | 0 | ||
| ||||
CK19 | (1+) | (2+) | (3+) | 0 |
| ||||
Hürthle cell metaplasia (8) | 4 (50%) | 4 (50%) | 0 | 0 |
PTC-like nuclear alteration (20) | 0 | 1 (5%) | 19 (95%) | 0 |
Papillary structure (5) | 3 (60%) | 2 (40%) | 0 | 0 |
Glomerular-like structure (10) | 0 | 5 (50%) | 3 (30%) | 2 (20%) |
| ||||
HBME-1 | (1+) | (2+) | (3+) | |
| ||||
Hürthle cell metaplasia (8) | 4 (50%) | 4 (50%) | 0 | 0 |
PTC-like nuclear alteration (20) | 19 (95%) | 1 (5%) | 0 | 0 |
Papillary structure (5) | 3 (60%) | 1 (20%) | 0 | 1 (20%) |
Glomerular-like structure (10) | 8 (80%) | 0 | 0 | 2 (20%) |